Indications
This site is intended for U.S. residents 18 years of age or older.
ELIQUIS (apixaban) is a prescription
medicine used in adults to reduce the risk of stroke and blood clots in people who have atrial fibrillation (AFib), a type of irregular heartbeat, not caused by a heart valve problem.
ELIQUIS (apixaban) is a prescription
medicine used in adults to treat blood clots in the veins of your legs (deep vein thrombosis-DVT) or lungs (pulmonary embolism-PE), and to reduce the risk of them occurring again after receiving treatment for blood clots.
ELIQUIS (apixaban) is a prescription
medicine used in children from birth and older to treat blood clots in the veins of legs and lungs (venous thromboembolism) after at least 5 days of initial anticoagulant treatment, and to reduce the risk of them happening again. ELIQUIS was not studied and is not recommended in children weighing less than 5.7 pounds (2.6 kg).
ELIQUIS (apixaban) is a prescription
medicine used in adults to help prevent a blood clot in the veins of your legs (deep vein thrombosis-DVT) and lungs (pulmonary embolism-PE) of people who have just had hip or knee replacement surgery.
Indications
ELIQUIS (apixaban) is a prescription
medicine used in adults to reduce the risk of stroke and blood clots in people who have atrial fibrillation (AFib), a type of irregular heartbeat, not caused by a heart valve problem.
ELIQUIS (apixaban) is a prescription
medicine used in adults to treat blood clots in the veins of your legs (deep vein thrombosis-DVT) or lungs (pulmonary embolism-PE), and to reduce the risk of them occurring again after receiving treatment for blood clots.
ELIQUIS (apixaban) is a prescription
medicine used in children from birth and older to treat blood clots in the veins of legs and lungs (venous thromboembolism) after at least 5 days of initial anticoagulant treatment, and to reduce the risk of them happening again. ELIQUIS was not studied and is not recommended in children weighing less than 5.7 pounds (2.6 kg).
ELIQUIS (apixaban) is a prescription
medicine used in adults to help prevent a blood clot in the veins of your legs (deep vein thrombosis-DVT) and lungs (pulmonary embolism-PE) of people who have just had hip or knee replacement surgery.
Eliquis is covered for
over 90% of patients
with commercial & Medicare Part D plans (as of May 7, 2025)
Sign up for ELIQUIS 360 Support to receive a series of
communications with helpful information.
How do I contact
ELIQUIS 360 support?
You can access ELIQUIS 360 Support in three ways:
Explore more information on this page.
Chat with Elise, our virtual assistant.
Talk to a live specialist by calling 1-855-ELIQUIS (354-7847), Monday – Friday, 8 AM – 8 PM (ET) or Saturday – Sunday, 9 AM – 6 PM (ET).
Do you have a Medicare Part D prescription drug plan?
This video provides an overview of information and resources that may be helpful to you.
COMMON INSURANCE COVERAGE TERMS
Select a term to view its definition.
CO-PAY
is a set rate you pay for prescriptions.
OUT-OF-POCKET COSTS
are expenses that are not reimbursed by your insurance and are paid for on your own.
Do you have a Medicare Part D
prescription drug plan?
FORMULARY
is the list of prescription drugs covered by a prescription drug plan or another insurance plan offering prescription drug benefits. Sometimes an insurance company may request that a formulary exception request be submitted.
PRIOR AUTHORIZATION
is when your doctor is required to obtain approval from your insurance plan before it will cover the costs of a specific medicine.
BENEFITS REVIEW
is a review of your pharmacy benefits to help identify your prescription coverage and potential out-of-pocket costs.
DEDUCTIBLE
refers to the set amount you pay for prescriptions before your insurance plan starts to pay.
Live specialists are here to:
If you have questions along the way, our live specialists are available at 1-855-ELIQUIS (354-7847), Monday – Friday 8 AM – 8 PM ET.
Sign up for ELIQUIS 360 Support to receive a series of communications to:
Share your story
STRENGTH IN SHARING PROGRAM
Strength in Sharing was established to give selected ELIQUIS patients an opportunity to share experiences and insights that may be helpful to other patients. Participants could possibly be featured in videos as well as a wide range of promotional materials if selected. If you’ve been prescribed ELIQUIS, you are invited to register your interest in being part of the Strength in Sharing program.
If you prefer, you may contact the Strength in Sharing program toll-free at 1-844-384-4957.
For additional help with ELIQUIS 360 Support, use the links above to chat with Elise or call 1-855-ELIQUIS (354-7847).
—BITSY
Bitsy was diagnosed with AFib not caused by a heart valve problem. She was compensated for her time and expenses.